FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition stimulating adenosine receptors and comprising one or some compounds of the formula (I) and new compounds of the formula (II) . The composition provides the effective modulation of the adenosine system.
EFFECT: valuable properties of modulators.
12 cl, 541 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PYRIMIDINES AND USE THEREOF AS JNK MODULATORS | 2007 |
|
RU2493155C2 |
DERIVATIVES OF 4-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2243221C2 |
DERIVATIVES OF PYRIDINE AND PYRIMIDINE, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION AND USING | 2003 |
|
RU2293731C2 |
DERIVATIVES OF 5-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244710C2 |
DERIVATIVES OF PYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2284997C2 |
DERIVATIVES OF NICOTINE- OR ISONICOTINE-BENZOTHIAZOLE AND MEDICINAL AGENT | 2002 |
|
RU2294933C2 |
SULFONAMIDES AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2162084C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
JAK INHIBITORS | 2010 |
|
RU2538204C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS | 2002 |
|
RU2270197C2 |
Authors
Dates
2006-06-20—Published
2001-02-15—Filed